PROM1 and lung carcinoma: Furthermore, CD133-expressing tumor cells has been found to mediate chemo-/radio-therapy resistance [15] and metastasis in lung cancers [16], thus, molecular and functional characterization of such population may provide valuable information to development of effective therapies for treatment of lung cancers.